Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs
Luke Timmerman Another six months have gone by, so it must be time for another deal for Forma Therapeutics. Sure enough, Watertown, MA-based Forma is announcing today it has struck a partnership to...
View ArticleForma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week
Luke Timmerman Forma Therapeutics has the hot hand among biotech startups in the early days of 2012. Today, it is announcing it has struck its second alliance with a Big Pharma company that wants...
View ArticleJoin Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3
Luke Timmerman Biotech companies once dreamed of building soup-to-nuts operations that put everything under one corporate flag. You’d have research, development, marketing, manufacturing all together...
View ArticleBiotech Wasn’t Immune to Job Loss in Great Recession, BIO Report Says
Luke Timmerman The biotechnology industry is often held up by public officials as an engine for producing lots of high-skill, high-wage jobs. But bioscience-based industries shed thousands of jobs in...
View ArticleForma Strikes $200M Deal With Celgene to Discover Cancer Drugs
Luke Timmerman Forma Therapeutics has never had trouble finding partners who want access to its early-stage drug discovery team, when most companies are cutting back there. But the Watertown, MA-based...
View ArticleCelgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker
Luke Timmerman Celgene is best known for taking a notoriously dangerous compound, thalidomide, and turning a derivative into a hugely successful cancer drug. But what fewer people may realize is that...
View ArticleJ.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex
Alex Lash The word “story” gets ill treatment at events like the J.P. Morgan Healthcare Conference. It often means an elevator pitch from a harried CEO to a distracted investor, or a few observations...
View ArticleBio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
One group of people in dire need of medical relief got good news this week. The first drug for postpartum depression was approved. With its complicated logistics, side effects, and potential high cost,...
View Article
More Pages to Explore .....